Literature DB >> 33004622

Cell Adhesion Molecules in Plasticity and Metastasis.

Jessica A Smart1, Julia E Oleksak2, Edward J Hartsough3.   

Abstract

Prior to metastasis, modern therapeutics and surgical intervention can provide a favorable long-term survival for patients diagnosed with many types of cancers. However, prognosis is poor for patients with metastasized disease. Melanoma is the deadliest form of skin cancer, yet in situ and localized, thin melanomas can be biopsied with little to no postsurgical follow-up. However, patients with metastatic melanoma require significant clinical involvement and have a 5-year survival of only 34% to 52%, largely dependent on the site of colonization. Melanoma metastasis is a multi-step process requiring dynamic changes in cell surface proteins regulating adhesiveness to the extracellular matrix (ECM), stroma, and other cancer cells in varied tumor microenvironments. Here we will highlight recent literature to underscore how cell adhesion molecules (CAM) contribute to melanoma disease progression and metastasis. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33004622      PMCID: PMC7785660          DOI: 10.1158/1541-7786.MCR-20-0595

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   6.333


  227 in total

Review 1.  Paracrine regulation of melanogenesis.

Authors:  X H Yuan; Z H Jin
Journal:  Br J Dermatol       Date:  2018-01-16       Impact factor: 9.302

Review 2.  Cell surface-associated mucins in signal transduction.

Authors:  Pankaj K Singh; Michael A Hollingsworth
Journal:  Trends Cell Biol       Date:  2006-08-09       Impact factor: 20.808

Review 3.  Mucins in cancer: function, prognosis and therapy.

Authors:  Donald W Kufe
Journal:  Nat Rev Cancer       Date:  2009-12       Impact factor: 60.716

Review 4.  From melanocytes to melanomas.

Authors:  A Hunter Shain; Boris C Bastian
Journal:  Nat Rev Cancer       Date:  2016-04-29       Impact factor: 60.716

5.  Cryo-EM Reveals Integrin-Mediated TGF-β Activation without Release from Latent TGF-β.

Authors:  Melody G Campbell; Anthony Cormier; Saburo Ito; Robert I Seed; Andrew J Bondesson; Jianlong Lou; James D Marks; Jody L Baron; Yifan Cheng; Stephen L Nishimura
Journal:  Cell       Date:  2020-01-16       Impact factor: 41.582

6.  Targeting the Achilles' heel of cancer cells via integrin-mediated delivery of ROS-generating dihydrolipoamide dehydrogenase.

Authors:  Avraham Dayan; Gideon Fleminger; Osnat Ashur-Fabian
Journal:  Oncogene       Date:  2019-03-14       Impact factor: 9.867

7.  Combined VLA-4-Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma.

Authors:  Jaeyeon Choi; Wissam Beaino; Ronald J Fecek; Kellsye P L Fabian; Charles M Laymon; Brenda F Kurland; Walter J Storkus; Carolyn J Anderson
Journal:  J Nucl Med       Date:  2018-06-29       Impact factor: 10.057

Review 8.  Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance.

Authors:  Farzana Ahmed; Nikolas K Haass
Journal:  Front Oncol       Date:  2018-05-24       Impact factor: 6.244

Review 9.  Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment.

Authors:  Heidi Harjunpää; Marc Llort Asens; Carla Guenther; Susanna C Fagerholm
Journal:  Front Immunol       Date:  2019-05-22       Impact factor: 7.561

Review 10.  Resistance to RAF inhibitors revisited.

Authors:  Edward Hartsough; Yongping Shao; Andrew E Aplin
Journal:  J Invest Dermatol       Date:  2013-10-10       Impact factor: 8.551

View more
  8 in total

Review 1.  Signal pathways of melanoma and targeted therapy.

Authors:  Weinan Guo; Huina Wang; Chunying Li
Journal:  Signal Transduct Target Ther       Date:  2021-12-20

2.  Multi-omics Profiling Shows BAP1 Loss Is Associated with Upregulated Cell Adhesion Molecules in Uveal Melanoma.

Authors:  Usman Baqai; Timothy J Purwin; Nelisa Bechtel; Vivian Chua; Anna Han; Edward J Hartsough; Jeffim N Kuznetsoff; J William Harbour; Andrew E Aplin
Journal:  Mol Cancer Res       Date:  2022-08-05       Impact factor: 6.333

Review 3.  Supramolecular lipid nanoparticles as delivery carriers for non-invasive cancer theranostics.

Authors:  Syeda Zunaira Bukhari; Kornelius Zeth; Maryam Iftikhar; Mubashar Rehman; Muhammad Usman Munir; Waheed S Khan; Ayesha Ihsan
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-10-28

4.  Transcriptome analysis reveals the potential biological function of FSCN1 in HeLa cervical cancer cells.

Authors:  Fengqin Guo; Yanliang Liu; Yanxiang Cheng; Qifan Zhang; Weili Quan; Yaxun Wei; Li Hong
Journal:  PeerJ       Date:  2022-02-02       Impact factor: 2.984

Review 5.  The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma.

Authors:  Piia Takabe; Hanna Siiskonen; Aino Rönkä; Kirsi Kainulainen; Sanna Pasonen-Seppänen
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

6.  Prognostic Implications and Immune Infiltration Characteristics of Chromosomal Instability-Related Dysregulated CeRNA in Lung Adenocarcinoma.

Authors:  Shengnan Guo; Tianhao Li; Dahua Xu; Jiankai Xu; Hong Wang; Jian Li; Xiaoman Bi; Meng Cao; Zhizhou Xu; Qianfeng Xia; Ying Cui; Kongning Li
Journal:  Front Mol Biosci       Date:  2022-03-28

7.  ZWZ-3, a Fluorescent Probe Targeting Mitochondria for Melanoma Imaging and Therapy.

Authors:  Zengjin Liu; Hailan Wang; Changzhen Sun; Yuanmin He; Tong Xia; Jianv Wang; Xia Xiong; Qingbi Zhang; Sijin Yang; Li Liu
Journal:  Front Pharmacol       Date:  2022-02-23       Impact factor: 5.810

8.  Using ELP Repeats as a Scaffold for De Novo Construction of Gadolinium-Binding Domains within Multifunctional Recombinant Proteins for Targeted Delivery of Gadolinium to Tumour Cells.

Authors:  Natalia V Pozdniakova; Oxana V Ryabaya; Alevtina S Semkina; Vsevolod A Skribitsky; Alexei B Shevelev
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.